
Clinical correlates of early onset antipsychotic treatment resistance
Author(s) -
Daniela Fonseca de Freitas,
Deborah Agbedjro,
Giouliana Kadra-Scalzo,
Emma Francis,
Isobel Ridler,
Megan Pritchard,
Hitesh Shetty,
Aviv Segev,
Cecilia Casetta,
Sophie Smart,
Anna Morris,
Johnny Downs,
Søren Rahn Christensen,
Nikolaj Bak,
Bruce J. Ki,
Daniel Ståhl,
Richard D. Hayes,
James H. MacCabe
Publication year - 2022
Publication title -
journal of psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.333
H-Index - 114
eISSN - 1461-7285
pISSN - 0269-8811
DOI - 10.1177/02698811221132537
Subject(s) - antipsychotic , cohort , schizophrenia (object oriented programming) , medicine , psychiatry , retrospective cohort study , pediatrics , psychosis , cohort study , psychology
There is evidence of heterogeneity within treatment-resistant schizophrenia (TRS), with some people not responding to antipsychotic treatment from illness onset and others becoming treatment-resistant after an initial response period. These groups may have different aetiologies.